Literature DB >> 30155722

In vitro assessment of hepatotoxicity by metabolomics: a review.

Matthias Cuykx1,2, Robim M Rodrigues3, Kris Laukens4,5, Tamara Vanhaecke3, Adrian Covaci6.   

Abstract

Omics technologies, and in particular metabolomics, have received an increasing attention during the assessment of hepatotoxicity in vitro. However, at present, a consensus on good metabolomics practices has yet to be reached. Therefore, in this review, a range of experimental approaches, applied methodologies, and data processing workflows are compared and critically evaluated. Experimental designs among the studies are similar, reporting the use of primary hepatocytes or hepatic cell lines as the most frequently used cell sources. Experiments are usually conducted in short time-frames (< 48 h) at sub-toxic dosages. Applied sample preparations are protein precipitation or Bligh-and-Dyer extraction. Most analytical platforms rely on chromatographic separations with mass spectrometric detection using high-resolution instruments. Untargeted metabolomics was typically used to allow the simultaneous detection of several classes of the metabolome, including endogenous metabolites that are not initially linked to toxicity. This non-biased detection platform is a valuable tool for generating hypothesis-based mechanistic research. The most frequently reported metabolites that are altered under toxicological impulses are alanine, lactate, and proline, which are often correlated. Other unspecific biomarkers of hepatotoxicity in vitro are the down-regulation of choline, glutathione, and 3-phospho-glycerate. Disruptions on the Krebs cycle are associated with increased glutamate, tryptophan, and valine. Phospholipid alterations are described in steatosis, lipo-apoptosis, and oxidative stress. Although there is a growing trend towards quality control, data analysis procedures do often not follow good contemporary metabolomics practices, which include feature filtering, false-discovery rate correction, and reporting the confidence of metabolite annotation. The currently annotated biomarkers can be used to identify hepatotoxicity in general and provide, to a certain extent, a tool for mechanistic distinction.

Entities:  

Keywords:  Drug-induced liver injury (DILI); Hepatotoxicity; In vitro; Liver; Metabolomics

Mesh:

Substances:

Year:  2018        PMID: 30155722     DOI: 10.1007/s00204-018-2286-9

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  18 in total

1.  Safety assessment of cosmetics by read across applied to metabolomics data of in vitro skin and liver models.

Authors:  Carine Jacques; Emilien L Jamin; Isabelle Jouanin; Cécile Canlet; Marie Tremblay-Franco; Jean-François Martin; Daniel Zalko; Yves Brunel; Sandrine Bessou-Touya; Laurent Debrauwer; Pierre-Jacques Ferret; Hélène Duplan
Journal:  Arch Toxicol       Date:  2021-08-30       Impact factor: 5.153

2.  Ultra-Performance Liquid Chromatography-Mass Spectrometry-Based Untargeted Metabolomics Reveals the Key Potential Biomarkers for Castor Meal-Induced Enteritis in Juvenile Hybrid Grouper (Epinephelus fuscoguttatus♀ × E. lanceolatus♂).

Authors:  Kwaku Amoah; Xiao-Hui Dong; Bei-Ping Tan; Shuang Zhang; Shu-Yan Chi; Qi-Hui Yang; Hong-Yu Liu; Xiao-Bo Yan; Yuan-Zhi Yang; Haitao Zhang
Journal:  Front Nutr       Date:  2022-06-16

3.  Systematic Identification of Molecular Targets and Pathways Related to Human Organ Level Toxicity.

Authors:  Tuan Xu; Leihong Wu; Menghang Xia; Anton Simeonov; Ruili Huang
Journal:  Chem Res Toxicol       Date:  2020-11-29       Impact factor: 3.973

4.  Exposure of HepaRG Cells to Sodium Saccharin Underpins the Importance of Including Non-Hepatotoxic Compounds When Investigating Toxicological Modes of Action Using Metabolomics.

Authors:  Matthias Cuykx; Charlie Beirnaert; Robim Marcelino Rodrigues; Kris Laukens; Tamara Vanhaecke; Adrian Covaci
Journal:  Metabolites       Date:  2019-11-04

5.  Involvement of Reactive Oxygen Species in the Hepatorenal Toxicity of Actinomycin V In Vitro and In Vivo.

Authors:  Fu-Juan Jia; Zhuo Han; Jia-Hui Ma; Shi-Qing Jiang; Xing-Ming Zhao; Hang Ruan; Wei-Dong Xie; Xia Li
Journal:  Mar Drugs       Date:  2020-08-15       Impact factor: 5.118

6.  Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis.

Authors:  Shuai-Shuai Chen; Ying Huang; Yu-Ming Guo; Shan-Shan Li; Zhuo Shi; Ming Niu; Zheng-Sheng Zou; Xiao-He Xiao; Jia-Bo Wang
Journal:  Front Med (Lausanne)       Date:  2021-03-29

7.  Integrating in vitro metabolomics with a 96-well high-throughput screening platform.

Authors:  Julia M Malinowska; Taina Palosaari; Jukka Sund; Donatella Carpi; Mounir Bouhifd; Ralf J M Weber; Maurice Whelan; Mark R Viant
Journal:  Metabolomics       Date:  2022-01-09       Impact factor: 4.290

8.  Combinatory Effects of Cerium Dioxide Nanoparticles and Acetaminophen on the Liver-A Case Study of Low-Dose Interactions in Human HuH-7 Cells.

Authors:  Benjamin C Krause; Fabian L Kriegel; Victoria Tartz; Harald Jungnickel; Philipp Reichardt; Ajay Vikram Singh; Peter Laux; Mohamed Shemis; Andreas Luch
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

9.  Metabolomics profiling of Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata extracts using UPLC-Q/TOF-MS.

Authors:  Zhaoyan Zhang; Liang Yang; Xiaoyan Huang; Yue Gao
Journal:  Chin Med       Date:  2019-10-26       Impact factor: 5.455

10.  Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury.

Authors:  Zhongyang Xie; Lingjian Zhang; Ermei Chen; Juan Lu; Lanlan Xiao; Qiuhong Liu; Danhua Zhu; Fen Zhang; Xiaowei Xu; Lanjuan Li
Journal:  Metabolites       Date:  2021-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.